1-2 of 2
A. Schulze
Close
Sort by
Journal Articles

Factors Influencing Complete Remission (CR) Rate in Patients ≥ 60 Years with Acute Myeloid Leukemia (AML): Report From the German AML Intergroup Study

Dietger Niederwieser, Verena S Hoffmann, MA., Rainer Krahl, MD, Wolfgang E. Berdel, MD, Maria Cristina Sauerland, Wolfgang Hiddemann, MD, PhD, Ute Hegenbart, MD, Bernhard Josef Woermann, MD, U. Krug, MD, Wolfram Pönisch, Vladan Vucinic, Karin Hebenstreit, Michael Cross, PhD, Christian Niederwieser, Markus Pfirrmann, A Schulze, Alwin Kraemer, Georg Maschmeyer, Mathias Freund, MD, S Scholl, Thomas Heinicke, D Haehling, Hans-Heinrich Wolf, MD, Thomas Büchner, MD
Journal: Blood
Blood (2012) 120 (21): 128.
https://doi.org/10.1182/blood.V120.21.128.128
Published: 2012
Journal Articles

High CR-Rate after Intensive Chemotherapy but Disappointing Results after Palliative Treatment in Patients with Acute Myeloid Leukemia Above the Age of 60 Years: An Analysis of the AML97#38 Study of the East German Hematology and Oncology Study Group (OSHO).

Cornelia Becker, R. Krahl, H.K. Al Ali, W. Poenisch, M. Cross, S. Heyn, A. Gerhardt, A. Schulze, U. Mahlknecht, D. Haehling, M. Schulze, M. Freund, E. Kettner, G. Doelken, H.H. Wolf, E. Zschuppe, N. Peter, A. Franke, U. Wedding, L. Uharek, U. Kreibich, A. Florschuetz, B. Opitz, N. Zojer, W. Helbig, Dietger Niederwieser
Journal: Blood
Blood (2007) 110 (11): 1854.
https://doi.org/10.1182/blood.V110.11.1854.1854
Published: 2007